IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Endonovo Therapeutics Inc (ENDV)

CUSIP: 29272H300 | NYSE | Healthcare · Biotechnology | Micro Cap | 2 institutional holders

Quarters

Q4 2025Q2 2025Q4 2024Q3 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Family CFO Inc60
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Family CFO Inc
60$00.0%ETFLowLos Altos, CA2026-01-23